CB8025-31735 PBC
This is a 52-week, placebo-controlled, randomized, Phase 3 study to evaluate the safety and efficacy of seladelpar in subjects with primary biliary cholangitis (PBC) and an inadequate response to or intolerance to ursodeoxycholic acid (UDCA).
Learn More
Please complete the form below if you are interested in joining a clinical study. Please note that not all who apply are accepted into a trial.
Menu
Newsletter
Sign up with your name and email address to obtain ongoing updates. Please know that you can ‘opt out’ at any time.
Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.
Get In Touch
We’d love to hear from you!
Excel Medical Clinical Trials LLC
7900 Glades Road, Suite 400
Boca Raton, FL 33434
7900 Glades Road, Suite 400
Boca Raton, FL 33434